NANOREPRO AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.845 EUR | -0.27% |
|
+6.03% | -7.52% |
| Sales 2021 | 163M 174M 14.51B | Sales 2022 | 38.79M 41.48M 3.46B | Capitalization | 28.45M 30.42M 2.54B |
|---|---|---|---|---|---|
| Net income 2021 | 29M 31.01M 2.59B | Net income 2022 | -3M -3.21M -268M | EV / Sales 2021 | 0.42 x |
| Net cash position 2021 | 27.87M 29.8M 2.49B | Net cash position 2022 | 31.26M 33.42M 2.79B | EV / Sales 2022 | -0.07 x |
| P/E ratio 2021 |
3.26
x | P/E ratio 2022 |
-7.64
x | Employees | 17 |
| Yield 2021 |
6.68% | Yield 2022 |
6.8% | Free-Float | 99% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | -0.27% | ||
| 1 week | +6.03% | ||
| Current month | +6.96% | ||
| 1 month | +1.93% | ||
| 3 months | -9.11% | ||
| 6 months | -20.13% | ||
| Current year | -7.52% |
1 week
1.65
1.89
1 month
1.612.00
Current year
1.612.15
1 year
1.612.84
3 years
1.6111.50
5 years
0.4022.40
10 years
0.4022.40
| Managers | Title | Age | Since |
|---|---|---|---|
Lisa Jüngst
CEO | Chief Executive Officer | - | 01/06/01 |
Olaf Stiller
FOU | Founder | 47 | 01/06/01 |
Stefan Pieh
DFI | Director of Finance/CFO | - | 01/21/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Olaf Stiller
FOU | Founder | 47 | 01/06/01 |
| Director/Board Member | - | 25/11/25 | |
| Director/Board Member | 40 | 23/18/23 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 1.845 | -0.27% | 5,936 |
| 25/24/25 | 1.85 | -2.12% | 6,947 |
| 24/24/24 | 1.89 | +5.59% | 29,548 |
| 23/24/23 | 1.79 | +3.47% | 14,819 |
| 22/24/22 | 1.73 | -0.57% | 1,758 |
Delayed Quote Xetra, April 26, 2024 at 09:06 pm IST
More quotes
Nanorepro AG is a Germany-based company active in the biotechnology sector. The Company is engaged in the research of stem cells, which are used in the medical treatment due to their ability to self-renew and differentiate to a range of specialized cell types. Nanorepro AG gathers samples of patientsâ stem cells and stores them for the future use. Its portfolio also comprises OTC rapid diagnostic tests, such as OvuQUICK, an ovulation test for women; GraviQUICK, a pregnancy test; MenoQUICK, a menopause test; VagiQUICK, a vaginal yeast test; GlutenCHECK, a test to detect celiac disease; CholesterinCHECK, a test to measure the level of total cholesterol, HDL and LDL, as well as FertiQUICK, a fertility test for men.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.52% | 25.37M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- NN6 Stock
